Parathyroid Carcinoma

• FDA approval · 2020-10-07
  FDA Approved: CINACALCET — Original Application (Camber Pharmaceuticals, Inc.)

  The FDA approved Camber Pharmaceuticals' original application for a generic cinacalcet hydrochloride product.

• FDA approval · 2020-05-18
  FDA Approved: CINACALCET — Supplemental Application (Strides Pharma Science Limited)

  The FDA approved a supplemental application for CINACALCET submitted by Strides Pharma Science Limited under ANDA209226, enabling a suppleme…

• FDA approval · 2018-03-08
  FDA Approved: CINACALCET — Original Application (Cipla USA Inc.)

  FDA approved Cipla USA Inc.'s generic cinacalcet (cinacalcet) under an original ANDA for its approved indications: secondary hyperparathyroi…

• FDA approval · 2017-05-23
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  FDA approved a supplemental application for Sensipar (cinacalcet hydrochloride) from Amgen Inc, relating to labeling changes for the drug.

• FDA approval · 2011-08-01
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  The FDA approves a supplemental application for Sensipar (cinacalcet hydrochloride) submitted by Amgen Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-11-12
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  The FDA approved Amgen's supplemental application for SENSIPAR (cinacalcet hydrochloride), resulting in updated labeling for the product.